Health
Chronicle Pharmabiz
NABL issues guidance on criteria for accreditation of medical imaging labs
THE National Accreditation Board for Testing and Calibration Laboratories (NABL) has issued guidance on specific criteria for accreditation of Medical Imaging-Conformity Assessment Bodies (MI-CAB) or medical imaging labs.
2 min |
February 5, 2026
Chronicle Pharmabiz
Govt imposes MIP for three APIs
THE Union ministry of commerce and industry has imposed Minimum Import Price (MIP) for three APIs - penicillins and its salts, amoxycillin and its salts, and 6-APA - restricting imports of these products valued under the MIP for a period of one year.
1 min |
February 5, 2026
Chronicle Pharmabiz
Panel asks MoA to integrate allopathy and Ayush
THE Parliamentary Panel on Health and Family Welfare has asked the Ministry of Ayush to work towards integrated healthcare facilities with collaborative synthesis between allopathy and Ayush systems of medicine.
1 min |
February 5, 2026
Chronicle Pharmabiz
Pharma assns explore investment opportunities in UP
IN order to explore investment opportunities in the growing Uttar Pradesh (UP) pharma industry, a high-level delegation of pharma associations like the IDMA, the Indian Pharmaceutical Alliance (IP Alliance) and the Organisation of Pharmaceutical Producers of India (OPPI) met Chief Minister (CM) of Uttar Pradesh Yogi Adityanath.
2 min |
February 12, 2026
Chronicle Pharmabiz
AI medical language tools changing healthcare access: Expert
ARTIFICIAL intelligence (AI)à supported medical language tools, today, convert technical terms into simpler explanations for patients with physical and cognitive disabilities.
1 min |
February 5, 2026
Chronicle Pharmabiz
Apollo Hospitals inks MoU with Roche Diagnostics
APOLLO Hospitals Enterprise grated healthcare provider, has announced an initiative to better leverage artificial intelligence (AI) to foster innovation, enhance patient care, and expedite clinical processes.
1 min |
February 5, 2026
Chronicle Pharmabiz
India-EU FTA boosts innovating med-tech sector
THE India-EU Free Trade Agreement provides substantial benefits for the pharmaceutical and medical devices sectors, subject to phased implementation and final ratification details.
1 min |
February 5, 2026
Chronicle Pharmabiz
'India-EU FTA has potential to be a game changer for pharma'
THE India-EU FTA has the potential to be a game-changer for Indian pharma and medtech companies.
2 min |
February 5, 2026
Chronicle Pharmabiz
PAN India CME reinforces evidence-based nutrition
PHYSICIANS Association for Nutrition (PAN) India has brought in a multidisciplinary approach to bridge research evidence and clinical practice in preventive health and nutrition.
1 min |
February 5, 2026
Chronicle Pharmabiz
Govt to do away with provisional regn of EC
As part of the series of amendments notified or proposed under the NDCT Rules 2019 to simplify the procedures and enhance ease of doing business, the Union Health Ministry has proposed another amendment to do away with requirements of granting of Provisional Certificate for registration of Ethics Committee (EC) related to biomedical and health research.
1 min |
February 12, 2026
Chronicle Pharmabiz
Experts unite to strengthen awareness, care for MS
MULTIPLE Sclerosis Society of India (MSSI) Bengaluru Chapter, in collaboration with the Rotary Action Group Against Multiple Sclerosis (RAGAMS), hosted an awareness and advocacy programme titled \"Navigating MS Together.\"
2 min |
February 5, 2026
Chronicle Pharmabiz
Healthcare sector sees facilities critical component for patient recovery
INDIAN healthcare sector is increasingly recognizing facility management as a critical component in improving patient recovery and overall care outcomes.
2 min |
February 5, 2026
Chronicle Pharmabiz
Industry optimistic US-India trade deal to boost exports
THE pharmaceutical industry is hopeful that the proposed reduction in US-India reciprocal taxes from 50% to 18% will provide greater cost competitiveness and improve export prospects. Industry participants believe the move could ease pricing pressures, enhance market access in the US, and support growth in India's pharma exports over the medium term.
2 min |
February 12, 2026
Chronicle Pharmabiz
Pharma, health shine in Budget 2026-27 with *1.05 lakh cr outlay
FINANCE Minister Nirmala Sitharaman, presenting her record-breaking ninth Union Budget in Parliament yesterday, signalled a paradigm shift for India's healthcare landscape, transitioning it from a social expenditure head to a high-value strategic asset.
1 min |
February 5, 2026
Chronicle Pharmabiz
Health Min to amend NDCT Rules on reporting of post approval changes
THE Union ministry of health has initiated efforts to include specific norms related to reporting of post approval changes to the licensed new drugs, both imported and manufactured in the country, to ensure their quality, safety and efficacy throughout the product lifecycle.
2 min |
February 12, 2026
Chronicle Pharmabiz
K'taka urged to set up vet drug cell within state FDA
THE Karnataka State Registered Pharmacists Association (KSRPA) has urged the state government to establish a dedicated veterinary drug cell within the state FDA, stressing that a specialised unit is essential to monitor the quality, safety, and pricing of animal-health medicines. The association has cautionedthe government that gaps in oversight are allowing substandard and overpriced veterinary products to reach the market, posing risks to both animal welfare and farmers' livelihoods.
1 min |
February 12, 2026
Chronicle Pharmabiz
Pfizer's sBLA for Hympavzi gets US FDA priority review status
PFIZER Inc. announced that the US FDA has accepted and granted Priority Review for the company's supplemental Biologics License Application (sBLA) for Hympavzi (marstacimab) to expand the approved indication to include the treatment of haemophilia A or B patients 6 years and older with inhibitors, and paediatric patients (ages 6 to 11) with haemophilia A or B without inhibitors.
2 min |
February 12, 2026
Chronicle Pharmabiz
Tindivanam Pharma Park in TN ready for manufacturers
In a move that significantly shifts Tamil Nadu’s pharmaceutical trajectory, Tindivanam Pharma Industrial Park is now officially open for manufacturing development.
2 min |
February 12, 2026
Chronicle Pharmabiz
Non-invasive therapeutic tech enables people to manage pain effectively: Expert
INDIA'S musculoskeletal experts see major change in pain management where compact, noninvasive therapeutic technologies are enabling people to manage pain more effectively within their daily lives.
2 min |
February 12, 2026
Chronicle Pharmabiz
Indian life sciences sector hails India-EU FTA
INDIA'S life sciences sector believes that the India-EU FTA (Free Trade Agreement) could accelerate drug approvals, cut certification costs, and ease manufacturing modifications, creating a more favourable environment for Indian generics and biosimilars to strengthen their presence in the European market.
1 min |
February 5, 2026
Chronicle Pharmabiz
EMA begins review of Tavneos
EUROPEAN Medicines Agency's human medicines committee has started a review of Tavneos (avacopan), following emerging information that raises questions regarding the data integrity of the Advocate study, which was the main study supporting the medicine's marketing authorisation in the European Union.
1 min |
February 5, 2026
Chronicle Pharmabiz
Experts hail affordable therapies in NCDs in Budget 2026
WITH the country's disease burden steadily shifting towards non-communicable diseases (NCDs) such as diabetes, cancer and autoimmune disorders, the Union Budget 2026 focus on advanced therapies, measures such as customs duty exemptions on 17 life-saving drugs, faster regulatory approvals, the creation of medical tourism hubs, and investments in allied healthcare talent development reflect a holistic approach to improving affordability, accessibility and quality of care, says Nirav Mehta, CEO & managing director, CORONA Remedies.
1 min |
February 5, 2026
Chronicle Pharmabiz
Centre to hike testing fees multifold under Sch B, B1 of Drug Rules
THE Union health ministry has initiated a process to increase the fees for various tests and analysis conducted by the Central and state drug laboratories by multifold, and to fix the fees of various other tests through an amendment of the Drugs Rules, 1945, with plans to increase the fees by 5% every year.
1 min |
February 5, 2026
Chronicle Pharmabiz
Dr Reddy's unveils report on non-animal testing methods
DR Reddy's, Humane World for Animals India and DBT BRIC Institute for Stem Cell Science and Regenerative Medicine (InStem) is accelerating India's drug development and improving patient outcomes through science driven, nonanimal testing methods.
1 min |
February 12, 2026
Chronicle Pharmabiz
'India-EU FTA positions Indian pharma talent to collaborate across EU market'
THE India-European Union (EU) Free Trade Agreement (FTA) positions Indian services, pharma and healthcare talent to compete and collaborate across a vast European market with greater predictability.
1 min |
February 5, 2026
Chronicle Pharmabiz
AICDF warning Sanofi India over whimsical trade policies
THE All India Chemists and Distributors Federation (AICDF) has formally lodged a complaint against Sanofi India Limited, alleging significant irregularities in the company's commercial circulars.
2 min |
February 5, 2026
Chronicle Pharmabiz
Pharma MNCs sentiments high over Union Budget 2026
UNION Budget 2026 has buoyed sentiments among multinational pharmaceutical companies, with industry leaders saying the measures will improve ease of doing business, accelerate product launches and reinforce India's position as a global pharma and life sciences hub.
2 min |
February 5, 2026
Chronicle Pharmabiz
AstraZeneca to invest $15 bn in China to expand medicines mfg
ASTRAZENECA Announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.
1 min |
February 5, 2026
Chronicle Pharmabiz
K'taka issues ban order on pvt practice by govt docs
KARNATAKA government issues orders on banning private practice by government doctors with immediate effect.
1 min |
February 5, 2026
Chronicle Pharmabiz
CDSCO issues document for e-submission of import applications for IVD
THE Central Drugs Standard Control Organisation (CDSCO) has released a draft guidance document to help the in-vitro diagnostics (IVD) medical devices importers for submission of import license applications through online portal.
2 min |